Author Topic: (Summary) Pathogenesis of PML and risks associated w/MS treatments--decade of lessons learned  (Read 136 times)

0 Members and 1 Guest are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 9822
  • MS diagnosed 1980
  • Location: Pacific Northwest
From The Lancet Neurology, "Pathogenesis of progressive multifocal leucoencephalopathy and risks associated with treatments for multiple sclerosis: A decade of lessons learned" (May 2018):


http://www.thelancet.com/journals/laneur/article/PIIS1474-4422(18)30040-1/fulltext?{$trackingTag}
MS Speaks--online for 17 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) since 12/16/20.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
148 Views
Last post September 28, 2016, 04:53:58 pm
by agate
0 Replies
113 Views
Last post June 11, 2017, 04:49:10 pm
by agate
0 Replies
182 Views
Last post December 23, 2017, 08:57:09 am
by agate
0 Replies
43 Views
Last post November 11, 2019, 08:19:03 pm
by agate
0 Replies
25 Views
Last post May 15, 2023, 09:30:23 pm
by agate